BeyondSpring Inc. (BYSI)
NASDAQ
Closed
Sep 3, 2026
Day's Range
0.622152 wk Range
0.5660Overview - BYSI - BeyondSpring Inc.
Key Statistics
Valuation
Enterprise Value
19.50M
P/E (Trailing)
‪-33.37‬
P/E (Forward)
‪-1.36‬
PEG Ratio
‪0.22‬
Price / Book
‪-0.90‬
EV / EBITDA
‪-2.32‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-22.86%‬
Return on Equity
‪4.19%‬
Ownership
Shares Outstanding
41.11M
Float
31.95M
Short % of Shares Outstanding
‪8.01%‬
Held by Insiders
‪17.40%‬
Held by Institutions
‪14.80%‬
Price stats
Beta
‪0.12‬
50-Day Avg
‪1.20‬
200-Day Avg
‪1.55‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BYSI - BeyondSpring Inc.
Peers - BYSI - BeyondSpring Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- BYSINASDAQBeyondSpring Inc.27.44MMarket Cap-157.68%52-week change-33.38P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt64.24BMarket Cap+25.70%52-week change40.24P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.35.60BMarket Cap-70.99%52-week change45.79P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE26.05BMarket Cap-8.41%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S17.75BMarket Cap+23.94%52-week change20.58P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.14.63BMarket Cap+27.46%52-week change-19.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.12.87BMarket Cap+15.26%52-week change179.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - BYSI - BeyondSpring Inc.
About
BeyondSpring Inc. is a clinical-stage biopharmaceutical company engaged in the development of innovative cancer therapies. The primary function of BeyondSpring is to advance novel therapeutics that address unmet needs in oncology, with a focus on improving patient outcomes through scientific innovation. The company is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
